US Physical Therapy (UPH) Stock Forecast & Price Target

1 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

UPH Analyst Ratings

Moderate Buy

2 Buy

1 Hold

0 Sell

Based on 3 analysts giving stock ratings to

Physical Therapy

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

UPH Stock 12 Month Forecast

Average Price Target

€79.61

▲(25.38% Upside)

Based on 3 Wall Street analysts offering 12 month price targets for US Physical Therapy in the last 3 months. The average price target is €79.61 with a high forecast of €83.89 and a low forecast of €75.33. The average price target represents a 25.38% change from the last price of €63.50.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"53":"€53","84":"€84","60.75":"€60.8","68.5":"€68.5","76.25":"€76.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":83.89383786,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€83.89</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":79.61354001000001,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€79.61</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":75.33324216,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€75.33</span>\n  </div></div>","useHTML":true}}],"tickPositions":[53,60.75,68.5,76.25,84],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2025","6":"Feb<br/>2026","9":"May<br/>2026","12":"Aug<br/>2026","25":"Aug<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,68.594,69.77091060461538,70.94782120923077,72.12473181384615,73.30164241846154,74.47855302307693,75.65546362769231,76.8323742323077,78.00928483692307,79.18619544153846,80.36310604615385,81.54001665076923,82.71692725538462,{"y":83.89383786,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,68.594,69.44165692384615,70.2893138476923,71.13697077153846,71.98462769538462,72.83228461923076,73.67994154307692,74.52759846692308,75.37525539076924,76.22291231461539,77.07056923846154,77.9182261623077,78.76588308615385,{"y":79.61354001000001,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,68.594,69.11240324307691,69.63080648615384,70.14920972923076,70.6676129723077,71.18601621538461,71.70441945846153,72.22282270153846,72.74122594461538,73.2596291876923,73.77803243076923,74.29643567384615,74.81483891692308,{"y":75.33324216,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":61.069,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":68.218,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":69.68,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":72.117,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":61.793,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":67.187,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":67.678,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":68.168,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":63.64,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":59.694,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":54.676,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":59.15,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":68.594,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target€83.89

Average Price Target€79.61

Lowest Price Target€75.33

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Jared Haase

William Blair

―

Hold

―

Reiterated

08/14/26

Analysts' Opinions Are Mixed on These Healthcare Stocks: US Physical Therapy (NYSE: USPH) and Adlai Nortye Ltd. Sponsored ADR (NASDAQ: ANL)

Michael Petusky

Barrington

€77.05→€83.89

Buy

32.12%

Upside

Reiterated

08/10/26

U.S. Physical Therapy price target raised to $98 from $90 at BarringtonU.S. Physical Therapy price target raised to $98 from $90 at Barrington

Joanna Gajuk

Bank of America Securities

€75.33

Buy

18.64%

Upside

Reiterated

08/06/26

US Physical Therapy: Solid Revenue Beat, Hospital Partnerships and Cash-Based Programs Drive Long-Term EBITDA Upside, Supporting Buy Rating

Benjamin Rossi

J.P. Morgan

€85.61→€77.05

Buy

21.33%

Upside

Reiterated

05/18/26

J.P. Morgan Sticks to Their Buy Rating for US Physical Therapy (USPH)

Constantine Davides

Citizens JMP

€96.73→€83.89

Buy

32.12%

Upside

Reiterated

05/08/26

U.S. Physical Therapy price target lowered to $98 from $113 at CitizensU.S. Physical Therapy price target lowered to $98 from $113 at Citizens

Jack Slevin

Jefferies

€94.17→€87.32

Buy

37.51%

Upside

Assigned

03/09/26

Analysts Conflicted on These Healthcare Names: Hims & Hers Health (NYSE: HIMS), US Physical Therapy (NYSE: USPH) and Evaxion Biotech (NASDAQ: EVAX)

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Jared Haase

William Blair

―

Hold

―

Reiterated

08/14/26

Analysts' Opinions Are Mixed on These Healthcare Stocks: US Physical Therapy (NYSE: USPH) and Adlai Nortye Ltd. Sponsored ADR (NASDAQ: ANL)

Michael Petusky

Barrington

€77.05→€83.89

Buy

32.12%

Upside

Reiterated

08/10/26

U.S. Physical Therapy price target raised to $98 from $90 at BarringtonU.S. Physical Therapy price target raised to $98 from $90 at Barrington

Joanna Gajuk

Bank of America Securities

€75.33

Buy

18.64%

Upside

Reiterated

08/06/26

US Physical Therapy: Solid Revenue Beat, Hospital Partnerships and Cash-Based Programs Drive Long-Term EBITDA Upside, Supporting Buy Rating

Benjamin Rossi

J.P. Morgan

€85.61→€77.05

Buy

21.33%

Upside

Reiterated

05/18/26

J.P. Morgan Sticks to Their Buy Rating for US Physical Therapy (USPH)

Constantine Davides

Citizens JMP

€96.73→€83.89

Buy

32.12%

Upside

Reiterated

05/08/26

U.S. Physical Therapy price target lowered to $98 from $113 at CitizensU.S. Physical Therapy price target lowered to $98 from $113 at Citizens

Jack Slevin

Jefferies

€94.17→€87.32

Buy

37.51%

Upside

Assigned

03/09/26

Analysts Conflicted on These Healthcare Names: Hims & Hers Health (NYSE: HIMS), US Physical Therapy (NYSE: USPH) and Evaxion Biotech (NASDAQ: EVAX)

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

AVBPArriVent BioPharma, Inc.

BTSGBrightSpring Health Services, Inc.

AMLXAmylyx Pharmaceuticals Inc

IMMXImmix Biopharma

JBIOJade Biosciences

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering US Physical Therapy

3 Months

Michael PetuskyBarrington

Success Rate

21/39 ratings generated profit

Average Return

+3.85%

Copying Michael Petusky's trades and holding each position for 3 Months would result in 53.85% of your transactions generating a profit, with an average return of +3.85% per trade.

1 Year

Michael PetuskyBarrington

Success Rate

18/39 ratings generated profit

Average Return

+1.66%

Copying Michael Petusky's trades and holding each position for 1 Year would result in 46.15% of your transactions generating a profit, with an average return of +1.66% per trade.

2 Years

Michael PetuskyBarrington

Success Rate

18/39 ratings generated profit

Average Return

+0.80%

Copying Michael Petusky's trades and holding each position for 2 Years would result in 46.15% of your transactions generating a profit, with an average return of +0.80% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

UPH Analyst Recommendation Trends

Rating

Apr 26

May 26

Jun 26

Jul 26

Aug 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, UPH has received 2 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. UPH average Analyst price target in the past 3 months is 79.61.

Each month's total comprises the sum of three months' worth of ratings.

UPH Financial Forecast

UPH Earnings Forecast

Next quarter’s earnings estimate for UPH is €0.64 with a range of €0.54 to €0.76. The previous quarter’s EPS was €0.64. UPH beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year UPH has Performed in-line its overall industry.

UPH Sales Forecast

Next quarter’s sales forecast for UPH is €183.39M with a range of €180.47M to €185.35M. The previous quarter’s sales results were €183.43M. UPH beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year UPH has Performed in-line its overall industry.

UPH Stock Forecast FAQ

What is DE:UPH’s average 12-month price target, according to analysts?

Based on analyst ratings, U.s. Physical Therapy’s 12-month average price target is 79.61.

What is DE:UPH’s upside potential, based on the analysts’ average price target?

U.s. Physical Therapy has 25.38% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is U.s. Physical Therapy a Buy, Sell or Hold?

U.s. Physical Therapy has a consensus rating of Moderate Buy, which is based on 2 buy ratings, 1 hold ratings and 0 sell ratings.

What is U.s. Physical Therapy’s share price target?

The average share price target for U.s. Physical Therapy is 79.61. This is based on 3 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €83.89 ,and the lowest forecast is €75.33. The average share price target represents 25.38% Increase from the current price of €63.5.

What do analysts say about U.s. Physical Therapy?

U.s. Physical Therapy’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 3 Wall Streets Analysts.

How can I buy shares of U.s. Physical Therapy?

To buy shares of DE:UPH, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

US Physical Therapy (UPH) Stock Forecast & Price Target

UPH Analyst Ratings

UPH Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering US Physical Therapy

UPH Analyst Recommendation Trends

UPH Financial Forecast

UPH Earnings Forecast

UPH Sales Forecast

UPH Stock Forecast FAQ

Detailed List of Analyst Forecasts